glp-1 효능 지아이롱제비티, 비만약 효과 높이는 유산균 요요·혈당 반등까지 완화” 바이킹, GLP-1·GIP작용제 비만 1상서 효능

[1] Institute for Health Metrics and Evaluation

From short-acting to long-acting formulations, the wide range of GLP- 1 receptor agonists available provides physicians with numerous options to tailor treatment to each patient's needs

The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis

Cell Metab 29 , 837843 (2019)

According to FDA labeling for Wegovy (semaglutide), patients should be evaluated after 12 weeks at the maintenance dose (2.4 mg weekly), with discontinuation considered if less than 5% body weight reduction has been achieved